News Releases
Press releases 2024
Oct 11, 2024
Quest PharmaTech Announces Results from AGM
May 30, 2024
Quest PharmaTech Announces Filing of 2024 Year End Financial Statements and Restated Fiscal 2023 Financial Statements, and Appointment of New Director
January 30, 2024
Quest Receives Cash Dividend Payment from OncoQuest
January 23, 2024
Oregovomab Phase III Clinical Study fails futility analysis; Data Safety Monitoring Board Recommends Overall Survival Follow Up for Potential Late Immune Effects and Clinical Benefits
Press releases 2023
September 13, 2023
Quest PharmaTech Provides Corporate Update
July 14, 2023
Quest PharmaTech Announces Results from AGM
July 10, 2023
Quest PharmaTech Provides Product Development Update
June 6, 2023
Quest PharmaTech Clarifies Agreement in Principle with OQP Bio Inc.
June 2, 2023
Quest PharmaTech Provides Corporate Update